Overview

Remegal Different Doses in Patients With Refractory Partial Seizures

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine weather different doses of Remegal are effective,safety and tolerant in Additional Therapy for Patients With Refractory Partial Seizures and pharmacokinetics definition
Phase:
Phase 2
Details
Lead Sponsor:
Valexfarm